Page last updated: 2024-08-21

adamantane and bortezomib

adamantane has been researched along with bortezomib in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dasmahapatra, G; Dent, P; Grant, S; Nguyen, TK1
Anderson, KC; BarilĂ , D; Chauhan, D; DePinho, RA; Hideshima, T; Podar, K; Raab, MS; Raje, N; Sattler, M; Tai, YT; Tonon, G; Yasui, H; Zhang, J1
de Bruin, G; Florea, BI; Hoogendoorn, S; Mazurek, J; Mock, ED; Overkleeft, HS; van den Nieuwendijk, AM; van der Marel, GA1
Alberti, P; Avezza, F; Bravin, A; Cavaletti, G; Ceresa, C; Gandin, V; Monfrini, M; Nicolini, G; Pellei, M; Santini, C; Semperboni, S1

Other Studies

4 other study(ies) available for adamantane and bortezomib

ArticleYear
Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl.
    Leukemia research, 2006, Volume: 30, Issue:10

    Topics: Adamantane; Antineoplastic Agents; Apoptosis; Benzamides; Boronic Acids; Bortezomib; Cell Line, Tumor; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Hydroquinones; Imatinib Mesylate; Kinetics; Mutation; Oxidative Stress; Piperazines; Point Mutation; Pyrazines; Pyrimidines; Reactive Oxygen Species

2006
Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma.
    Cancer research, 2007, Feb-15, Volume: 67, Issue:4

    Topics: Adamantane; Apoptosis; Benzamides; Boronic Acids; Bortezomib; Caspase Inhibitors; Caspases; Cell Growth Processes; Dexamethasone; Humans; Hydroquinones; Imatinib Mesylate; Leukemia, Erythroblastic, Acute; Melphalan; Multiple Myeloma; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-jun; Pyrazines; Pyrimidines; Transfection; Up-Regulation

2007
Enantioselective synthesis of adamantylalanine and carboranylalanine and their incorporation into the proteasome inhibitor bortezomib.
    Chemical communications (Cambridge, England), 2016, Mar-14, Volume: 52, Issue:21

    Topics: Adamantane; Boron Compounds; Bortezomib; Cell Line, Tumor; Humans; Phenylalanine; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Stereoisomerism; Sulfonium Compounds

2016
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)
    Neurotoxicity research, 2018, Volume: 34, Issue:1

    Topics: Action Potentials; Adamantane; Animals; Antineoplastic Agents; Bortezomib; Carcinoma; Cell Line, Tumor; Cells, Cultured; Cisplatin; Copper; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Ganglia, Spinal; Gold; Humans; Mice; Mice, Inbred C57BL; Neuronal Outgrowth; Neurons; Organophosphorus Compounds; Peripheral Nerves; Polymerization; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Tubulin

2018